AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Phase I study to begin for therapeutic vaccine for hepatitis.

Vaccine Weekly

| March 03, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 MAR 3 - (NewsRx.com & NewsRx.net) -- Genencor International, Inc., (GCOR) will begin phase I safety and immunogenicity testing for its DNA-based therapeutic vaccine to treat hepatitis B.

Trials are scheduled to begin under an investigational new drug application (IND) filed by Genencor in December 2003.

Epimmune, Inc., collaborated on the design and preclinical development of the vaccine under its collaboration agreement with Genencor and will receive a milestone payment as a result of the IND filing.

"This first IND for Genencor represents important progress in our healthcare business," said Mark A. Goldsmith, MD, PhD, Genencor's senior vice president, healthcare.

He continued: "In less than 3 years, we've shown that we can ...

Related articles from newspapers, magazines, journals, and more
Genencor International's $66 Million World-Class Technology Center Opens Doors.
Press release article from: Business Wire August 16, 1996 700+ words
...Aug. 16, 1996--Genencor International Inc., the largest...headquarters. The Genencor International Technology Center...in Palo Alto. The Genencor International Technology Center...
Biotech enterprise completes acquisition; strengthens global market position....
Press release article from: PR Newswire March 30, 1990 700+ words
...three companies will be known as Genencor International. In January, the Kodak-Cultor...the three units that make up Genencor International combine complementary capabilities...significant production capacity. Genencor International opens its doors as one of the largest...
Robert E. Leach named president and CEO of Genencor International.
Press release article from: PR Newswire September 14, 1990 700+ words
...PRESIDENT AND CEO OF GENENCOR INTERNATIONAL ROCHESTER, N...of directors of Genencor International today appointed...took the name Genencor International to capitalize...
Genencor International, Inc. to Present at CSFB's First Chemical Industry...
Press release article from: PR Newswire September 12, 2003 700+ words
Genencor International, Inc. today announced that...officer, and president of Genencor International, Inc. will provide an overview...October 1st, 2003. About Genencor International, Inc. Genencor International...
Mitchell named executive vice president of Genencor International. (W. Thomas...
Press release article from: PR Newswire September 26, 1990 700+ words
...EXECUTIVE VICE PRESIDENT OF GENENCOR INTERNATIONAL ROCHESTER, N.Y., Sept. 26 /PRNewswire/ -- Genencor International, one of the world's...firm. "Our vision at Genencor International is to deliver innovation...
Genencor International, Inc. Sells Snomax Technologies Business
Press release article from: PR Newswire January 7, 1997 700+ words
...Jan. 7 /PRNewswire/ -- Genencor International, Inc. announced today the sale...Rochester, New York based division of Genencor International, Inc., which manufactures and...on its core enzyme businesses. Genencor International, Inc. formed in 1990, is a joint...
Genencor International, Inc. Invites You to Join Its Second Quarter Earnings...
Press release article from: PR Newswire July 30, 2003 700+ words
In conjunction with Genencor International, Inc.'s second quarter...Financial Officer. What: Genencor International, Inc.'s Second Quarter...Contact: Ruey-Li Hwang, Genencor International, Inc., 650-846...
Genencor International, Inc. Invites You to Join Its First Quarter Earnings...
Press release article from: PR Newswire April 28, 2003 700+ words
In conjunction with Genencor International, Inc.'s first quarter...Financial Officer. What: Genencor International, Inc.'s First Quarter...Contact: Ruey-Li Hwang, Genencor International, Inc., 650-846...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA